Table 5.
Characteristics of the prevalent cohort: GOLD A/B and GOLD C/D
| GOLD category A/B | GOLD category C/D | |
|---|---|---|
| Sample size, n (%) | 32,723 (66.4) | 16,563 (33.6) |
| Age at point prevalence, mean (SD) | 69.9 (11.2) | 70.5 (10.3) |
| Sex, n (%) | ||
| Male | 16,725 (51.1) | 8,417 (50.8) |
| Female | 15,998 (48.9) | 8,146 (49.2) |
| Age at diagnosis, mean (SD) | 64.3 (11.0) | 63.7 (10.4) |
| Time since diagnosis (months), mean (SD) | 72.5 (62.0) | 87.1 (70.5) |
| Comorbidities, n (%) | ||
| Myocardial infarction | 2,620 (8.0) | 1,507 (9.1) |
| Diabetes | 6,227 (19.0) | 3,348 (20.2) |
| Hypertension | 11,361 (34.7) | 5,633 (34.0) |
| Osteoporosis | 3,430 (10.5) | 2,266 (13.7) |
| Anxiety | 564 (1.7) | 437 (2.6) |
| Depression | 902 (2.8) | 550 (3.3) |
| Smoking history, n (%) | ||
| Unknown | 4,643 (14.2) | 1,779 (10.7) |
| Current smoker | 8,852 (27.1) | 4,698 (28.4) |
| Never smoked | 3,176 (9.7) | 1,138 (6.9) |
| Ex-smoker | 16,052 (49.1) | 8,948 (54.0) |
Abbreviations: GOLD, Global Initiative for Chronic Obstructive Lung Disease; GOLD A, low symptoms, low risk; GOLD B, high symptoms, low risk; GOLD C, low symptoms, high risk; GOLD D, high symptoms, high risk; n, number of patients; SD, standard deviation.